News
17d
Clinical Trials Arena on MSNJ&J reports new data from Phase III trial of icotrokinra for plaque psoriasisThe primary endpoint was met, with 57% of subjects treated with the therapy achieving clear or almost clear skin.
Pustular psoriasis and chronic plaque psoriasis both show high levels ... How to treat itchy pustules on foot If you have itchy pustules on your foot, you should see your doctor to get a diagnosis.
The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...
Plaque psoriasis, a chronic autoimmune disorder that ... throat, skin, nails, feet, or genitals), pain, redness or swelling at injection site, stomach flu (gastroenteritis), and acne.
A study of JNJ-2113 for the treatment of participants with plaque psoriasis involving special areas (scalp, genital, and/or palms of the hands and the soles of the feet) (ICONIC-TOTAL).
NCT06095102), which evaluated icotrokinra in patients with plaque psoriasis affecting special areas (scalp, genital, and palms of the hands and soles of the feet) were also announced. Results ...
I broke out in guttate, inverse, and plaque psoriasis from head to toe. It lasted for seven months. For those seven months, I didn’t feel like myself. The pain was constant. I couldn’t be ...
A study of JNJ-2113 for the treatment of participants with plaque psoriasis involving special areas (scalp, genital, and/or palms of the hands and the soles of the feet) (ICONIC-TOTAL).
and/or hands and feet) with overall IGA score of 0 or 1 with at least a 2-grade improvement as the primary endpoint.6 About Plaque PsoriasisPlaque psoriasis (PsO) is a chronic immune-mediated ...
ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously 84% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results